Posted on
17 dicembre 2014
Merlano M, Monteverde M, Strola G, Barriere J, Etienne-Grimaldi MC, Miraglio E, Lattanzio L, Vivenza D, Messa F, Lo Nigro C, Milano G: “Antibody-dependent cell-mediated cytotoxicity (ADCC) evolution under treatment by cetuximab and links with treatment outcome in colorectal cancer (CRC) patients”, ASCO Annual Meeting, Chicago, 1-5 giugno 2012.